Advertisement

Topics

UPDATE 3-McKesson says drug prices competitive but not volatile like 2017

17:12 EST 1 Feb 2018 | Topix

The comments from the nation's biggest drug distributor come after a rocky couple of years for distributors of generic drugs, whose profits and revenues declined because of lower prices. Generic drug prices fell amid increasing supply, heightened political scrutiny into high prices as well as a record number of regulatory approvals for new medicines.

Original Article: UPDATE 3-McKesson says drug prices competitive but not volatile like 2017

NEXT ARTICLE

More From BioPortfolio on "UPDATE 3-McKesson says drug prices competitive but not volatile like 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...